Study identification

EU PAS number

EUPAS12086

Study ID

28880

Official title and acronym

IDENTIFYING OPPORTUNITIES FOR EARLIER DIAGNOSIS OF IDIOPATHIC PULMONARY FIBROSIS IN ROUTINE CARE IN THE UK: A RETROSPECTIVE CLINICAL COHORT STUDY (OPPORTUNITIES FOR EARLIER IPF DIAGNOSIS)

DARWIN EU® study

No

Study countries

United Kingdom

Study description

In the UK, all patients who ultimately receive a diagnosis of IPF will have first presented in the primary care setting. Thus by carrying out a historical review of the primary care records for patient in the years preceding their IPF diagnosis, it should be possible to identify common patterns (trends) in healthcare resource utilization (HRU) and identify potential “red flags” to support decision support tools to aid earlier diagnosis.With a view to identifying potential opportunities for earlier referral to specialists and (ultimately) earlier diagnosis of IPF, this study aims to:(i) Evaluate patients’ patterns of HRU in the years preceding their IPF diagnosis.(ii) Characterise the clinical features of patients at the time of their IPF diagnosis.

Study status

Finalised
Research institutions and networks

Institutions

Networks

Respiratory Effectiveness Group (REG)
Belgium
Denmark
France
Germany
Greece
Hungary
Italy
Netherlands
Spain
Sweden
United Kingdom
First published:
04/06/2024
Network
ENCePP partner

Contact details

Richeldi Luca

Primary lead investigator

Study timelines

Date when funding contract was signed

Planned:
Actual:

Study start date

Planned:
Actual:

Date of final study report

Planned:
Actual:
Sources of funding
Other

More details on funding

Respiratory Effectiveness Group
Regulatory

Was the study required by a regulatory body?

Unknown

Is the study required by a Risk Management Plan (RMP)?

Not applicable